Moderna (MRNA) PT Raised to $131 at JPMorgan on Post 1Q Contracts

July 20, 2021 6:06 AM EDT
Get Alerts MRNA Hot Sheet
Price: $142.19 --0%

Rating Summary:
    8 Buy, 12 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 21 | New: 51
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

JPMorgan analyst Cory Kasimov raised the price target on Moderna (NASDAQ: MRNA) to $131.00 (from $127.00) while maintaining a Neutral rating to account for additional contracts in 2021 that were signed after 1Q earnings.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change

Related Entities

JPMorgan, Earnings